Can a common blood thinner protect critically ill kids from catheter clots?

NCT ID NCT04924322

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether enoxaparin, a blood thinner, can prevent blood clots caused by central venous catheters in critically ill children. Researchers will enroll 258 children up to 17 years old and adjust the dose based on age. The goal is to see if age affects how well the drug works, while monitoring for bleeding risks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Enoxaparin (a blood thinner, also known as Lovenox or Clexane)
What this could lead to
If successful, this could provide a safer, age-appropriate way to prevent dangerous blood clots from catheters in critically ill children, reducing complications.
What could go wrong
This is a mid-stage trial with 258 participants, so results may not apply to all children. Enoxaparin carries a risk of bleeding, which could be serious in critically ill patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEEP VENOUS THROMBOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness Hemorrhage venous thromboembolism Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Arkansas Children's Hospital

    RECRUITING

    Little Rock, Arkansas, 72202, United States

  • Children's Hospital Colorado

    RECRUITING

    Aurora, Colorado, 80045, United States

  • Children's Hospital St. Louis

    RECRUITING

    St Louis, Missouri, 63110, United States

  • Children's Hospital Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

  • Children's Hospital of Illinois at OSF Saint Francis Medical Center

    RECRUITING

    Peoria, Illinois, 61637, United States

  • Children's Hospital of Philadelphia

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Children's Hospital of Richmond

    WITHDRAWN

    Richmond, Virginia, 23219, United States

  • Children's of Alabama

    RECRUITING

    Birmingham, Alabama, 35233, United States

  • Dell Children's Medical Canter

    RECRUITING

    Austin, Texas, 78723, United States

  • Golisano Children's Hospital

    RECRUITING

    Rochester, New York, 14642, United States

  • Hassenfeld Children's Hospital

    RECRUITING

    New York, New York, 10016, United States

  • Johns Hopkins All Children's

    RECRUITING

    St. Petersburg, Florida, 33701, United States

  • Maria Fareri Children's Hospital

    RECRUITING

    Valhalla, New York, 10595, United States

  • Nationwide Children's Hospital

    WITHDRAWN

    Columbus, Ohio, 43205, United States

  • New York Presbyterian Hospital

    RECRUITING

    New York, New York, 10065, United States

  • Penn State Hershey Children's Hospital

    RECRUITING

    Hershey, Pennsylvania, 17033, United States

  • Stead Family Children's Hospital

    RECRUITING

    Iowa City, Iowa, 52242, United States

  • UH Rainbow Babies & Children's Hospital

    RECRUITING

    Cleveland, Ohio, 44106, United States

  • UTSW Medical Center; Children's Medical Center of Dallas

    RECRUITING

    Dallas, Texas, 75235, United States

  • University of Florida -UF Health

    RECRUITING

    Gainesville, Florida, 32610, United States

  • University of Oklahoma

    RECRUITING

    Oklahoma City, Oklahoma, 73104, United States

  • Yale-New Haven Children's Hospital

    RECRUITING

    New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.